Fundraising Fox

Boston Millennia Partners

Venture capital

Boston · Seed–Late Stage · 8 people tracked

Also known as Boston Millennia Partners Limited Partnership · GLEN VENTURES MANAGMENT, INC

Fox Verdict
Sign up to see your fit

Investment thesis

Boston Millennia Partners is a private equity firm that invests in healthcare and life sciences companies.

Source: firm website, verified Jul 28, 2026.

Stage
Seed–Late Stage
Check
$3M – $5M
HQ
Boston, Massachusetts, US
Instruments
Equity
Founded
1984
AUM
$700M
VC funds
3
Tracked investments
5

Team · 8 people

from curated & public directories
Elizabeth Callow· Senior Associatein

What they invest in

from 3 of 5 portfolio companies

AI & Machine Learning ×2Healthtech ×2Digital Health ×1Medical Devices ×1SaaS ×1Sales Tech ×1

HQs:United States×5

Investments · 5 tracked

founders shown can be your intro path

By year:2025 · 12024 · 12023 · 12018 · 14 dated

ArxchitectAug 2025SEC filingmedium confidence

Clemmons, US

Nate Peaty(Executive Officer, Director)Adam Orsborn(Executive Officer, Director)

Board seatRen Roome· per SEC Form D · $2.5M raise · filed Oct 2025

CotaFeb 2018SEC filingmedium confidence

HealthtechNew York, US

Stuart Goldberg(Executive Officer)Andrew Pecora(Director)Eric Schultz(Executive Officer, Director)Elizabeth Rushforth(Executive Officer)Thomas Gallucci(Executive Officer)Andrew Norden(Executive Officer)

Board seatDana Callow, Jr.· per SEC Form D · $40M raise · filed Feb 2018

Co-investorsEssex Woodlands Healthcare Partners

KorioOct 2023

Korio is a clinical technology company offering a randomization and trial supply management (RTSM/IRT) platform for trial sponsors.

Doylestown, US

Ryan Keane(Executive Officer, Director)Chuck Harris(Executive Officer, Director)

BoardAustin Poole(Director)Hugh R. Roome(Director)B. Bobby Bahram(Director)

Co-investorsBIP VenturesExcelerate Health Ventures

S2N Healths2nhealth.cominApr 2024

S2N Health provides commercial intelligence, analytics, and go-to-market strategy services for medtech, diagnostics, digital health, and drug delivery companies, from startups to global enterprises.

AI & Machine LearningHealthtechMedical DevicesSales TechBoston, US

Amy Siegel(CEO & Co-Founder)inTim Kofol(CTO & Co-Founder)inTimothy Kofol(Executive Officer, Director)Leah Shea(Chief Product Officer)in

BoardRoome Hugh(Director)Andrew Schwab(Director)in

Co-investorsExcelerate Health VenturesRittenhouse VenturesRobin Hood Ventures

Xevantxevant.comin

Xevant offers an automated data analytics and reporting platform for pharmacy benefit organizations, using AI to standardize diverse data formats, analyze pharmacy claims, and generate reports and repricing outputs.

AI & Machine LearningDigital HealthSaaSLehi, US

BRANDON NEWMAN(Executive Officer, Director)Brandon Newman(CEO)PETE TANTILLO(Executive Officer)JEFF LININGER(Executive Officer)DANIEL TELFORD(Executive Officer)DON DEGOYLER(Director)

Co-investorsHCAP PartnersTech Council VenturesMartinson VenturesTCV

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Boston Millennia Partners invest at?
Boston Millennia Partners invests at the Seed, Growth, Late Stage stages.
What is Boston Millennia Partners's typical check size?
Boston Millennia Partners typically writes checks of $3M – $5M.
What sectors does Boston Millennia Partners focus on?
Boston Millennia Partners focuses on Biotech, Enterprise Software, Healthtech, Medical Devices, SaaS.
Where is Boston Millennia Partners located?
Boston Millennia Partners is headquartered in Boston, US.

Similar investors

Featured in lists